Aalberts N.V.: Aalberts strengthens hydronic flow control position in eco-friendly buildings
Utrecht, 15 April 2021
Aalberts N.V. has reached an agreement to acquire 100% of the shares of Sentinel Performance Solutions Group Limited (Sentinel) based in Daresbury (UK), generating an annual revenue of approximately GBP 20 million with 60 FTE.
Sentinel is specialised in the cleaning, protecting and maintenance of heating and cooling systems in eco-friendly buildings through the optimisation of water quality. The Sentinel portfolio of additives, filters, and scale protection ensures optimum temperature transfer to all applicable parts in heating and cooling systems. This contributes significantly to energy savings, improves the system performance and extends the lifetime.
The Sentinel product range will further strengthen the existing portfolio of Aalberts hydronic flow control, offering integrated solutions to increase the energy efficiency of heating and cooling systems in eco-friendly buildings from source to emitter. The strong sales organisation of Aalberts hydronic flow control will drive the growth of Sentinel’s product range in regions and segments where Sentinel is not yet active.
Utilising the combined strength and knowledge of our teams will result in a long-term innovation roadmap, aimed at driving significant future growth in improving the energy efficiency of heating and cooling systems for our end users. The digital services developed by Aalberts in recent years, will be part of this roadmap.
The experienced management team of Sentinel, led by David Barrett, will continue to manage the company. Sentinel will become the competence centre of water quality within Aalberts hydronic flow control, including the existing water quality activities of Aalberts hydronic flow control in France. Sentinel’s base location in Daresbury (UK) will utilise the resources of Aalberts hydronic flow control in St Helens (UK) to facilitate future growth.
The results of Sentinel will be consolidated as of 1 May 2021. The acquisition will directly contribute to the earnings per share and will be financed from existing credit facilities.
Please visit www.sentinelprotects.com for additional information.
+31 (0)30 3079 301 (from 8:00 am CEST)
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Changes in Marimekko’s management – Jussi Siitonen steps down from Marimekko’s Board6.5.2021 07:45:00 CEST | Press release
Marimekko Corporation, Stock Exchange Release, 6 May 2021 at 8.45 a.m. Changes in Marimekko’s management – Jussi Siitonen steps down from Marimekko’s Board Jussi Siitonen has announced that he will resign immediately from his position as a member of the Board of Directors of Marimekko. Siitonen was today appointed CFO of Fiskars as of 3 November 2021 at the latest, which creates a conflict of interest with his duties as a Board member in Marimekko. According to the Articles of Association, Marimekko’s Board of Directors comprises a minimum of four and a maximum of seven ordinary members. As of today, the Board consists of Elina Björklund, Carol Chen, Mika Ihamuotila, Mikko-Heikki Inkeroinen, Catharina Stackelberg-Hammarén and Tomoki Takebayashi. The Board is chaired by Mika Ihamuotila and vice-chaired by Elina Björklund. MARIMEKKO CORPORATION Corporate Communications Anna Tuominen Tel. +358 40 5846944 firstname.lastname@example.org DISTRIBUTION: Nasdaq Helsinki Ltd Key media Marimekko is
DNO Returns to Profitability, Ups Tawke License Production Guidance6.5.2021 07:00:00 CEST | Press release
Oslo, 6 May 2021 – DNO ASA, the Norwegian oil and gas operator, today reported operating profit of USD 66 million in the first quarter of 2021, following four quarters of losses triggered by market perturbations from the global Covid pandemic. The turnaround was driven by solid production, cost optimization, higher oil prices and regularization of payments from Kurdistan. The Company stepped up spend early in the year with drilling of new wells and workovers of existing ones in its flagship Tawke license to sustain gross operated production from the Tawke and Peshkabir fields at 112,000 barrels of oil per day (bopd) in the first quarter, up from 110,000 bopd in the previous quarter. Net production attributable to the Company’s interest across the portfolio, including from DNO’s North Sea oil and gas assets, stood just shy of 100,000 barrels of oil equivalent per day (boepd). In another positive development during the quarter, Kurdistan initiated principal payments towards Tawke license
ForFarmers N.V.: ForFarmers first quarter 2021 Trading Update6.5.2021 07:00:00 CEST | Press release
Lochem, 6 May 2021 ForFarmers first quarter 2021 Trading Update Highlights first quarter 20211: Volume Total Feed2: up (1.8%); due to like-for-like volume growth in clusters Germany/Poland and the United Kingdom and due to the acquisition of De Hoop Mengvoeders in the Netherlands Volume compound feed: up (1.0%); the like-for-like volume growth in cluster Germany/Poland and the acquisition of De Hoop Mengvoeders was larger than the like-for-like volume decline in clusters Netherlands/Belgium and the United KingdomGross profit: down (-2.8%); the growth in cluster Netherlands/Belgium could not compensate the unexpected decline in cluster Germany/Poland in combination with the decline in the United Kingdom Underlying EBITDA: down (-12.8%); due to gross profit decline and despite like-for-like cost savings. Results and developments of the first quarter 2021 are compared to those of the first quarter 2020, unless stated differentlyTotal Feed covers the entire ForFarmers product portfolio and
ObsEva Announces First Quarter 2021 Financial Results and Business Update6.5.2021 07:00:00 CEST | Press release
-Yselty® for uterine fibroids: US New Drug Application submissionplanned in Q3:21; European marketing approval recommendation anticipated in Q4:21- -Yselty® for endometriosis: Readout from Phase 3 EDELWEISS 3 study expected in Q4:21- -Ebopiprant: Phase 2b dose ranging study planned to initiate in Q4:21 based on positive Phase 2a proof of concept- -Actively pursuing new indications and partnerships to maximize value of pipeline candidates- GENEVA, Switzerland and BOSTON, MA– May6, 2021 – ObsEva SA (NASDAQ: OBSV)(SIX: OBSN) (ObsEva or the Company), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today reported financial results for the quarter ended March 31, 2021 and provided a business update. “The outset of 2021 was marked with a prioritization of capitalization and commercialization, and we have made significant progress on both fronts,” said Brian O’Callaghan, CEO of ObsEva. “In the first quarter of 2021, we raised o
Hexagon Ragasco receives first order in 2021 from key customer in South-Asia6.5.2021 07:00:00 CEST | Press release
Hexagon Ragasco, a Hexagon Composites company, received its first order in 2021 from a long-term customer in South Asia. The total estimated value of the order is USD 3.8 million (approx. NOK 32 million). Driving energy transformation The use of LPG for cooking produces practically no particulates. Its CO2 footprint is 20% lower than that of heating oil and 50% lower than coal. Use of Hexagon Ragasco’s easy-to-handle lightweight, LPG composite cylinders provide a safer and cleaner fuel alternative, while also enabling people to spend less time cooking and gathering fuel, and more time on education and income generation. “This region of the world is facing the tough effects of the pandemic. Continuing our work with key customers in this region to support their local efforts to meet basic domestic cooking needs safely and efficiently is gratifying,” says Skjalg Sylte Stavheim, President Hexagon Ragasco. Timing Hexagon Ragasco’s cylinders will be produced and delivered in Q2 2021. For mor
ING posts 1Q2021 net result of €1,005 million6.5.2021 06:59:00 CEST | Press release
ING posts 1Q2021 net result of €1,005 million 1Q2021 result before tax of €1,463 million; capital position remains strong at 15.5%• Net interest income up on 4Q2020, supported by the benefit from TLTRO III, which more than oﬀset liability margin pressure. • Robust growth in fee income of 9.1% year-on-year, especially on investment products. • 1Q2021 had a low level of risk costs. Expenses were under control, but included some incidental costs due to restructuring. Lending and customer deposits increase• Net core lending growth of €17.8 billion in 1Q2021 as TLTRO funds were applied to support the economy; net customer deposits grew by €8.1 billion, reflecting ongoing impacts of Covid-19 pandemic and lockdowns. • Primary customer base was stable at 13.8 million in 1Q2021, reflecting impacts of the pandemic. CEO statement “ING delivered a strong performance in the first quarter of 2021. The sharp rebound in net profit compared to the year-earlier period was driven by a good increase in fe
ObsEva appoints Clive Bertram as Chief Commercial Officer6.5.2021 06:55:00 CEST | Press release
GENEVA, Switzerland and BOSTON, MA – May 6, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the appointment of Clive Bertram as Chief Commercial Officer and member of ObsEva’s Executive Committee, effective May 10, 2021. Wim Souverijns has served as Chief Commercial Officer of ObsEva since November 2018 and will leave the Company on June 30, 2021 to pursue a new opportunity. He will work to ensure a smooth transition with Clive Bertram. “We are delighted to welcome Clive to the executive team, especially at such an exciting time for the Company,” said Brian O’Callaghan, Chief Executive Officer of ObsEva. “Clive has a demonstrated track record of leadership and I am confident he will play a key role in further strengthening our relationships with investors and potential partners as we become a commercial company and prepare for the launch of Yselty in Europe, a